Intelligence registryBrowse all public records
Public-source dossiershu-xj-07e2c9f132243a82d2ee81c68c0de549f7d29476
Public source recordorganizationPublic record

Xinjiang Jindakang Pharmaceutical Retail Chain Co., Ltd., Artush City Gedalian Branch

Authority: Special Interest RiskCoverage: cnRecord snapshot: 2026-07-06
Evidence class
Public source record
Coverage
cn
Record category
Public record
Record snapshot
2026-07-06
Linked public records

No verified ownership, offshore or transport links have been attached to this record yet.

Source and status notice
Verify the underlying publisher and original record before relying on this information. Always verify the live source record and identifiers before relying on this page.

Compliance Profile

"Public-record notice: Xinjiang Jindakang Pharmaceutical Retail Chain Co., Ltd., Artush City Gedalian Branch appears in public source record data. The record is informational and should be checked against the original publisher before legal, financial or counterparty decisions are made."

Banking Impact

This public record does not establish a banking prohibition. Any onboarding or transaction decision should use the original source, a verified identity match and the institution's applicable legal framework.

Legal Status

This is an informational public record, not a sanctions, exclusion or enforcement conclusion unless the page expressly identifies an official issuing authority and record.

Public source metadata

Source: Special Interest Risk
Full Legal NameXinjiang Jindakang Pharmaceutical Retail Chain Co., Ltd., Artush City Gedalian Branch
Known aliases新疆金达康医药零售连锁有限公司阿图什市格达良分店
Countries / jurisdictionscn
Source datasets
SHU UYGHUR COMPANIESshu_uyghur_companies
Record statusInformational public record
Record timelineFirst seen: 2024-12-19T21:42:45 • Last seen: 2026-06-05T08:32:11
Risk Topicspoi

Compliance Context Review

Independent assessment

SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for entities seeking to clarify a public record or counterparty signal.

Source-list verification
Banking and counterparty exposure memo
Regulatory status and remediation triage
Request Risk Assessment
Confidential Review
Report an error or request a correction
Export PDFSubscriber Only